Govt Orders Recall as Natco Cancer Drug Fails Toxin Test

Summary posted by Meridian on 7/24/2009
Source: Trading Markets
Author: n/a

The government of India has ordered the Hyderbad, India, based company Natco Pharma, to recall its breast cancer drug Albupax from the market within two weeks. Tests showed that the drug, a nanotechnology-based generic version of a drug by the United States company Abraxis, could cause damage to the liver. A Natco spokesperson confirmed that the company had suspended production of the the drug, but sought to defend it by saying that testing procedures for nanotechnology-based products are complex. A government official said that "Abraxis had collected samples of Albupax and got them tested in several labs in the US. Its complaint to the Indian regulator was based on those studies of the collected samples. Natco Pharma has also been asked to stop production of Albupax till investigations are over." The Drug Controller General of India (DCGI) said that Albupax failed endotoxin tests. Drug complications can cause serious problems for breast cancer patients who are also undergoing surgery, radiotherapy and chemotherapy. The article can be viewed online at the link below.

As tagged by Meridian Institute:

Related Forums:

NDN Home

Manage Subscription

Search News Archives

Nanotechnology Quintuples Heating Capacity of Solar Water Heaters -- Renewable Energy Magazine (9/1/2010) Researchers at the University of Rio de Janeiro (UFRJ), Brazil, have developed a solar heating system that uses nanotechnology to heat water to five times the temperature of a conventional system, while also permitting the collector surface area to retain up to 98 percent of heat from solar radiation. [More]

Pakistan's Science Minister Attacks Funding Cuts -- SciDev.Net (9/1/2010) The Pakistan government has cuts its funds for the Pakistan Ministry of Science and Technology's 2010-2011 budget by almost half, causing the science minister, Muhammad Azam Khan Swati, to criticize his own government. [More]

Nanotechnology: Small wonders -- Nature (9/1/2010) This article takes an in-depth look at the United States National Nanotechnology Initiative (NNI)'s first 10 years - to find out where the money went and what the initiative plans to do next. [More]

Nanotech on Farmers' Fields -- Silicon Nutrition (8/31/2010) A plant nutrition study that addresses nano-sized plant nutrients is now available from the Landbouwkundige Uitgeverij G.C. van den Berg (Veenendaal, The Netherlands). [More]

More News...

Learn how to include these headlines on your own website by clicking here.

Please email us if you require text-only versions of the daily emails.








our team contact us site map	Govt Orders Recall as Natco Cancer Drug Fails Toxin Test Summary posted by Meridian on 7/24/2009 Source: Trading Markets Author: n/a The government of India has ordered the Hyderbad, India, based company Natco Pharma, to recall its breast cancer drug Albupax from the market within two weeks. Tests showed that the drug, a nanotechnology-based generic version of a drug by the United States company Abraxis, could cause damage to the liver. A Natco spokesperson confirmed that the company had suspended production of the the drug, but sought to defend it by saying that testing procedures for nanotechnology-based products are complex. A government official said that "Abraxis had collected samples of Albupax and got them tested in several labs in the US. Its complaint to the Indian regulator was based on those studies of the collected samples. Natco Pharma has also been asked to stop production of Albupax till investigations are over." The Drug Controller General of India (DCGI) said that Albupax failed endotoxin tests. Drug complications can cause serious problems for breast cancer patients who are also undergoing surgery, radiotherapy and chemotherapy. The article can be viewed online at the link below. The original article may still be available at www.tradingmarkets.com/.site/news/Stock%20News/2438786/ As tagged by Meridian Institute: Health And Medical: Diseases Implications: Human Enhancement, Human Health Risks, Governance, Economic Competitiveness Materials And Manufacturing: Manufacturing Nanomaterials: Naturally Occurring Regions: North America, East and South Asia and the Pacific Stakeholders: Government, Industry Related Forums: Health and Medical Materials and Manufacturing Human Health Risks and Worker Safety Economic Competitiveness Governance print format	NDN Home Subscribe Manage Subscription Search News Archives Nanotechnology Quintuples Heating Capacity of Solar Water Heaters -- Renewable Energy Magazine (9/1/2010) Researchers at the University of Rio de Janeiro (UFRJ), Brazil, have developed a solar heating system that uses nanotechnology to heat water to five times the temperature of a conventional system, while also permitting the collector surface area to retain up to 98 percent of heat from solar radiation. [More] Pakistan's Science Minister Attacks Funding Cuts -- SciDev.Net (9/1/2010) The Pakistan government has cuts its funds for the Pakistan Ministry of Science and Technology's 2010-2011 budget by almost half, causing the science minister, Muhammad Azam Khan Swati, to criticize his own government. [More] Nanotechnology: Small wonders -- Nature (9/1/2010) This article takes an in-depth look at the United States National Nanotechnology Initiative (NNI)'s first 10 years - to find out where the money went and what the initiative plans to do next. [More] Nanotech on Farmers' Fields -- Silicon Nutrition (8/31/2010) A plant nutrition study that addresses nano-sized plant nutrients is now available from the Landbouwkundige Uitgeverij G.C. van den Berg (Veenendaal, The Netherlands). [More] More News... Learn how to include these headlines on your own website by clicking here. Please email us if you require text-only versions of the daily emails.